Just landed at FDA. Let’s talk about psylocibin today. Psylocibin is the naturally occurring, psychedelic ingredient found in around 200 species of mushrooms. Like cannabis, it is believed that psylocibin use by humans predates recorded history by at least a few thousand years. Also like cannabis, psylocibin has always... Read more
We are not convinced by the HIDTA report. Earlier this month, Billy J. Williams, U.S. Attorney for the District of Oregon, responded to a recent federal report on drug policy in Oregon by calling the state’s cannabis program “out of control.” The report in question was published by the Oregon-Idaho... Read more
CBD Webinar: Join Us Tomorrow at 11am PST!
Uncategorized August 15, 2018
Don’t miss this one! Cannabidiol (“CBD”) products are suddenly everywhere. But as much as opportunity and possibility have opened in the hemp-derived CBD industry, so too have legal pitfalls and snares that can confuse just about anyone breaking into this new market. When it comes to navigating the trails... Read more
Cannabis Cybersecurity: Why Hacking Back is a Bad Idea
Recreational MarijuanaUncategorized August 13, 2018
Hacking back isn’t the answer, unfortunately. As I have discussed for the last two weeks, cannabis businesses have become increasingly vulnerable to cyberattacks. It is natural for a company victimized by data breaches to want to retaliate by hacking back. However, under current U.S. law, which is codified under... Read more
Bipartisan Bill Would (Sort of) Protect Federal Employees’ Off-Work Marijuana Use
Uncategorized August 12, 2018
Will the laws change for federal worker marijuana use? Could the federal government protect the rights of federal employees to use marijuana in states where its legal? Possibly. A bipartisan bill was introduced in Congress on July 28 proposing to protect federal employees’ personal and private use of marijuana... Read more
Definitely worth a shot. Every business thrives on brand differentiation. One of the most effective ways to promote public identification and recognition is to enhance and protect your brand. Your brand is of course your name but it is also your logo. Beyond that, really, it’s everything about you.... Read more
The End of Industrial Hemp Prohibition: Almost There!
Medical MarijuanaRecreational MarijuanaUncategorized July 5, 2018
We like this one. For the past few months, the U.S. Senate has made significant strides toward legalizing industrial hemp. That is welcome news to many of our clients, who are working with the plant under federally approved Agricultural Pilot Programs, while also dealing with almost absurdly complex issues... Read more
A Refresher and an Update: The (Cannabis) STATES Act
IndustryMarijuana Laws, Regulations, & PoliticsNational & Federal Marijuana NewsUS Marijuana News June 30, 2018
It seems like every year, the old pot guard in Congress tries its hand at some form of marijuana legalization. Although these sorts of actions attract headlines (and votes?), they never seem to go anywhere. But for the first time ever, a real and legitimate bipartisan “respect states’ rights”... Read more
BREAKING NEWS: Senate Bill Introduced to End Cannabis Prohibition
Marijuana Laws, Regulations, & PoliticsNational & Federal Marijuana NewsUS Marijuana News June 28, 2018
Our thoughts on the new Senate cannabis bill. Yesterday, U.S. Senator Chuck Schumer (D-NY) introduced the Marijuana Freedom and Opportunity Act (“MFOA”). The MFOA is also co-sponsored by Senators Bernie Sanders (I-VT), Tim Kaine (D-VA), and Tammy Duckworth (D-IL). Coming on the heels of the STATES Act, the MFOA... Read more
BREAKING NEWS: Epidiolex, First Non-Synthetic Cannabis Drug, Approved
Health & FitnessMarijuana Laws, Regulations, & PoliticsMedical MarijuanaNational & Federal Marijuana NewsUS Marijuana News June 25, 2018
Big win today for GW Pharma. In a previous post, we discussed GW Pharmaceuticals, the leading developer of cannabis-based pharmaceuticals. Today, the FDA announced the approval of GW Pharmaceutical’s drug Epidiolex (cannabidiol), an oral solution for treatment of seizures associated with two rare forms of epilepsy, Lennox-Gastaut syndrome and... Read more
